Shares of Stericycle, Inc. (NASDAQ:SRCL - Get Free Report) reached a new 52-week high during trading on Friday . The company traded as high as $61.54 and last traded at $61.52, with a volume of 3849486 shares traded. The stock had previously closed at $58.90.
Analyst Ratings Changes
A number of analysts have commented on SRCL shares. Royal Bank of Canada restated a "sector perform" rating and set a $62.00 price target (down from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. StockNews.com assumed coverage on shares of Stericycle in a report on Sunday, September 1st. They issued a "hold" rating on the stock. Keefe, Bruyette & Woods boosted their target price on shares of Stericycle from $135.00 to $142.00 and gave the stock an "outperform" rating in a report on Tuesday, June 4th. Finally, Truist Financial boosted their target price on shares of Stericycle from $50.00 to $62.00 and gave the stock a "hold" rating in a report on Tuesday, June 4th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Stericycle presently has a consensus rating of "Hold" and a consensus target price of $74.00.
Get Our Latest Stock Report on SRCL
Stericycle Stock Performance
The firm's 50-day moving average price is $58.65 and its two-hundred day moving average price is $54.13. The firm has a market capitalization of $5.72 billion, a PE ratio of -280.00, a P/E/G ratio of 3.23 and a beta of 1.11. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55.
Stericycle (NASDAQ:SRCL - Get Free Report) last released its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.04. The business had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. As a group, research analysts predict that Stericycle, Inc. will post 2.29 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in Stericycle by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 8,969,118 shares of the business services provider's stock valued at $444,509,000 after purchasing an additional 52,576 shares in the last quarter. Capital Research Global Investors lifted its stake in Stericycle by 11.4% in the first quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider's stock valued at $351,732,000 after acquiring an additional 679,974 shares during the last quarter. Earnest Partners LLC lifted its stake in Stericycle by 12.4% in the first quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider's stock valued at $129,766,000 after acquiring an additional 271,025 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Stericycle by 7.0% in the second quarter. Dimensional Fund Advisors LP now owns 2,171,659 shares of the business services provider's stock valued at $126,238,000 after acquiring an additional 142,814 shares during the last quarter. Finally, Schroder Investment Management Group lifted its stake in Stericycle by 8.1% in the fourth quarter. Schroder Investment Management Group now owns 1,739,644 shares of the business services provider's stock valued at $86,217,000 after acquiring an additional 129,822 shares during the last quarter. 98.82% of the stock is owned by hedge funds and other institutional investors.
About Stericycle
(
Get Free Report)
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Read More
Before you consider Stericycle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.
While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
